Tag: Samsung Biologics

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Samsung Biologics

Biologics Contract Manufacturing Market on a Tear $14.4 Billion in 2022, Poised to Double ...

Added to Collection on: 2024-01-17 23:15:09

Tags for this article:

Pharmacy
Biopharmaceuticals
Healthcare in India
Pharmaceutical industry in India
Contract manufacturing organization
WuXi Biologics
Samsung Biologics
Lonza Group
Food and Drug Administration
Biosimilar
Cambrex Corporation
Pharmaceutical industry in China

Click the tags to see associated articles and topics

View Article Details
Mansfield Advisors considers the evolving roles of CDMOs - Investors in Healthcare

Added to Collection on: 2024-01-18 20:33:30

Tags for this article:

Research and development in the United States
Contract manufacturing organization
Drug manufacturing
Outsourcing
Samsung Biologics
Catalent
Eli Lilly and Company
Strategic partnership
Supply chain
Pharmaceutical industry
LinkedIn

Click the tags to see associated articles and topics

View Article Details
Biotechnology Contract Manufacturing Market in 2024 Detailed Study Analysis

Added to Collection on: 2024-02-16 15:28:26

Tags for this article:

Pharmacy
Biotechnology
Pharmaceuticals policy
WuXi Biologics
Biopharmaceutical
Pharmaceutical industry in India
Pharmaceutical industry in China
Contract manufacturing organization
Samsung Biologics
gsk plc
Pharmaceutical industry
Boehringer Ingelheim

Click the tags to see associated articles and topics

View Article Details
Biotechnology Contract Manufacturing Market Anticipated to reach $24.8 As Revealed ... - WhaTech

Added to Collection on: 2024-04-23 16:05:23

Tags for this article:

Biotechnology
Healthcare in India
Pharmaceutical industry in India
Biopharmaceuticals
Samsung Biologics
Contract manufacturing organization
WuXi Biologics
Biosimilar
Pharmaceutical industry in China
Biotechnology in India
Lonza Group

Click the tags to see associated articles and topics

View Article Details
Alvotech And Teva's Selarsdi™ (ustekinumab-aekn), Biosimilar To Stelara® Approved By FDA

Added to Collection on: 2024-05-01 12:19:39

Tags for this article:

Immunosuppressants
Monoclonal antibodies
Disease-modifying antirheumatic drugs
Biopharmaceuticals
Biosimilar
TNF inhibitors
Adalimumab
Ustekinumab
Sandoz
Biocon
Amgen
Samsung Biologics
Johnson & Johnson
Johnson & Johnson's

Click the tags to see associated articles and topics

View Article Details
Biologics Market Worth USD 717.0 Billion From 2024 to 2031 | BioSpace

Added to Collection on: 2024-05-06 13:46:26

Tags for this article:

Biotechnology products
Pharmacy
Biotechnology
Biopharmaceuticals
Pharmaceutical industry
Biosimilar
Novartis
Samsung Biologics
Eli Lilly and Company
Food and Drug Administration
Pharmaceutical industry in India
Biologics license application

Click the tags to see associated articles and topics

View Article Details
$19.81 Billion Large Molecule Drug Substance Contract - GlobeNewswire

Added to Collection on: 2024-05-14 14:33:39

Tags for this article:

Pharmaceutical industry
Pharmacy
Contract manufacturing organization
Drug manufacturing
Biopharmaceutical
Biosimilar
Samsung Biologics
Food and Drug Administration
WuXi Biologics
Catalent
Samsung
Medication

Click the tags to see associated articles and topics

View Article Details
AstraZeneca Loses Bid to Block Soliris Biosimilar During Appeal - Bloomberg Law News

Added to Collection on: 2024-06-18 16:30:25

Tags for this article:

Specialty drugs
Immunosuppressants
Monoclonal antibodies
Orphan drugs
Samsung
Samsung Biologics
Eculizumab
Alexion Pharmaceuticals
AstraZeneca
Biosimilar
Biopharmaceutical
Pharmaceutical industry in India
AstraZeneca plc
Alexion Pharmaceuticals Inc.
Samsung BioLogics Co

Click the tags to see associated articles and topics

View Article Details
Biologics Safety Testing Market worth $7.2 billion by 2029 - WhaTech

Added to Collection on: 2024-06-28 23:04:07

Tags for this article:

Pharmacy
Contract research organizations
Biotechnology
Biotechnology products
Biopharmaceutical
Pharmaceutical industry
Pharmaceutical industry in India
Thermo Fisher Scientific
Samsung Biologics
WuXi AppTec
Biocon
Merck Group

Click the tags to see associated articles and topics

View Article Details
Biologics Market Size To Reach $1,793.9 Billion By 2031 | CAGR 18.2%: The Insight Partners

Added to Collection on: 2024-10-24 14:36:01

Tags for this article:

Biotechnology
Biopharmaceutical
Pharmaceutical industry
Pharmacy
Samsung Biologics
WuXi Biologics
Biocon
Pharmaceutical industry in India
Food and Drug Administration
Vaccine
Contract manufacturing organization
AstraZeneca

Click the tags to see associated articles and topics

View Article Details